Existing methods for preoperative diagnosis of lymph node metastasis are inadequate.

Getty Images


January 24, 2024 — Nonfunctional pancreatic neuroendocrine tumors, while rare, are primarily treated through surgery. The presence or absence of lymph node metastasis considerably influences the selection of surgical and other treatment approaches. Particularly controversial is the necessity of surgery for tumors smaller than 2 cm as current clinical guidelines provide no clear consensus. Existing methods for preoperative diagnosis of lymph node metastasis are inadequate. 

To address the aforementioned challenge, the Tsukuba team has created a predictive model by integrating radiomics features extracted from CT and MRI images using artificial intelligence deep-learning techniques. This model has demonstrated an 89% success rate in predicting lymph node metastasis, a rate that rises to 91% when the model is validated with data from an external hospital. Furthermore, the performance of the model remains consistent, irrespective of the tumor size being larger or smaller than 2 cm. 

In conclusion, the model can help predict lymph node metastasis. Moreover, the model equips surgeons with a crucial tool for selecting the most appropriate surgical procedures and treatment strategies, potentially transforming patient outcomes in the challenging medical field. 

 

For more information: https://www.tsukuba.ac.jp/en/ 


Related Content

News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | RSNA

Sept. 22, 2026 — The Radiological Society of North America (RSNA) is now offering a certificate program that equips ...

Time September 24, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Ultrasound Imaging

Sept. 16, 2026 — Ultrasound AI, Inc., a developer of artificial intelligence for medical imaging with a focus on ...

Time September 17, 2026
arrow
News | CT Angiography (CTA)

Sept. 15, 2026 — A new study published in the Journal of the American College of Radiology (JACR) found that an ...

Time September 15, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Breast Imaging

Sept. 10, 2026 — An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more ...

Time September 10, 2026
arrow
Subscribe Now